Pembrolizumab (MK-3475) for patients (pts) with advanced colorectal carcinoma (CRC): Preliminary results from KEYNOTE-028

Date 27 September 2015
Event European Cancer Congress 2015
Session Immunotherapy in Cancer II
Topics Cancer Immunology and Immunotherapy
Presenter O’Neil, B.